Publication | Closed Access
PEGylated 2D-nanomaterials alleviate Parkinson's disease by shielding PIP2 lipids to inhibit IP3 second messenger signaling
15
Citations
39
References
2022
Year
NanoparticlesNanomedicineNeurodegenerative DiseasesEngineering2D-nanomaterials Alleviate ParkinsonTherapeutic NanomaterialsMedicinePip2 LipidsNano-drug DeliveryBiomedical EngineeringPharmacologyProtein NanoparticlesIp3 Second Messenger
| Year | Citations | |
|---|---|---|
Page 1
Page 1